Dr. Megha Saroha: Pediatric Oncologist in Delhi | Narayana Health

Dr. Megha Saroha

MBBS, MD (Pediatrics),
DM (Pediatric Oncology),
Fellowship (BMT) Associate Consultant

  • SpecialityOncology - Paediatric

  • HospitalDelhi - Dharamshila Narayana Superspeciality Hospital, Gurugram - Narayana Superspeciality Hospital, Gurugram

×

Warning message

The subscription service is currently unavailable. Please try again later.

Narayana Health » Delhi » Oncology Paediatric » Dr Megha Saroha

Brief Profile

Dr. Megha Saroha finished her MBBS from Maulana Azad Medical College, New Delhi followed by MD (Pediatrics) from University College of Medical Sciences, New Delhi. She worked in Pediatric Hematology–Oncology and BMT unit at Sir Gangaram Hospital for a year followed by senior residency at UCMS and GTB hospital. She pursued DM in Pediatric oncology from Tata memorial hospital, Mumbai. She then worked as a specialist SR at TMH, Mumbai and HBCH, Varanasi. She was further trained at Advanced Centre for treatment, research and education (Tata memorial Centre), Mumbai in bone marrow transplantation.

Qualification

  • MBBS – Maulana Azad Medical College, New Delhi
  • MD (Pediatrics) – University College of Medical Sciences, New Delhi
  • DM (Pediatric Oncology) – Tata Memorial Hospital, Mumbai
  • Fellowship (BMT)- Advanced Center for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai

Fields of Expertise

  • Pediatric and adolescent (0 – 18 year) hematological malignancies
  • Pediatric and adolescent (0 – 18 year) solid tumors
  • Pediatric and adolescent (0 – 18 year) hematopoietic stem cell transplantation (BMT)

Awards & Recognition

  • Dr S. T. Achar Endowement Award for Research paper at 51th National Conference of Indian Academy of Pediatrics, January 2014

Professional Memberships & Certifications

  • Indian academy of Pediatrics– Life member
  • Pediatric hematology oncology chapter, Mumbai

Publications

  • Saroha, M., Faridi, M., Batra, P., Kaur, I., &Dewan, D. (2015). Immunogenicity and safety of early vs delayed BCG vaccination in moderately preterm (31–33 weeks) infants. Human Vaccines &Immunotherapeutics, 11, 2864 – 2871
  • Gupta, A., Kumar, A., Chandha, B., &Saroha, M. (2014). Perinatal bilateral testicular torsion: A rare emergency with review of literature. Asian Journal of Medical Sciences, 5, 103-105.
  • Saroha, M., Batra, P., Dewan, P., &Faridi, M. (2015). Genital injuries in neonates following breech presentation. Journal of neonatal-perinatal medicine, 8 4, 421-5 .
  • Sankar, V., Batra, P., Saroha, M.,&Sadiza, J. (2017). Parental satisfaction in the traditional system of neonatal intensive care unit services in a public sector hospital in North India. South African Journal of Child Health, 11, 54-57.
  • Ramanathan, S., Saroha, M., Prasad, M., Vora, T., Qureshi, S., Kembhavi, S., Ramadwar, M., Laskar, S., Khanna, N., Chinnaswamy, G., &Banavali, S. (2019). Promising outcomes of extracranial germ cell tumours (eGCTs) in children & adolescents: Perspective from a developing country. European Urology Supplements, 18, 38.
  • Saroha, M., &Moulik, N. (2020). COPING with CORONA: A developing country perspective on managing children with cancer during COVID-19 pandemic. Cancer Research, Statistics, and Treatment, 3, 97 - 101.
  • Publications for books:
  • Saroha, M., Sachdeva. A. (2015). Chapter-21 Oncological Emergencies

Key Procedures Performed

  • Childhood cancers both blood cancers (Acute leukemia : Acute lymphoblastic leukemia, AML, CML, JMML, Non Hodgkin lymphoma, Hodgkin lymphoma) and solid tumors (abdominal masses, soft tissues masses, brain tumors, bone tumors)

Rare/ Unique Skills

  • Pediatric chemo-immunotherapy
  • Autologous transplant for high risk and relapsed malignancies
  • Allogeneic transplant for benign and malignant diseases
  • After completion of treatment follow up care

Languages Spoken

Hindi, English